Torrent Pharma's operating profit rose, but higher interest cut net profit
Revenue grew +12.41% YoY and margins improved, but interest expense jumped 378.72%; the stock's initial +1.93% rise was below its usual post-results move.
Filed 23 May 2026, 12:02 IST · after market close · Torrent Pharmaceuticals Ltd (TORNTPHARM)
Key takeaways
- Standalone operating profit rose 15.55% YoY as revenue grew +12.41% and operating margin expanded 0.99 percentage points.
- Net profit fell 1.48% YoY because interest expense surged 378.72% to Rs 225 cr, more than offsetting the operating gain.
- Operating margin narrowed 1.81 percentage points QoQ to 36.67% as expenses grew +8.32%, faster than revenue at +5.23%.
Price around the results
Operating growth did not reach reported profit
Torrent Pharmaceuticals reported standalone revenue growth of +12.41% YoY, while operating profit increased +15.55%. The gain did not carry through to net profit, which declined 1.48% to Rs 467 cr. Interest expense rose 378.72% YoY to Rs 225 cr, taking the main pressure on profit before tax.
Sequential margin decline reflects faster cost growth
Revenue increased +5.23% QoQ, but expenses grew +8.32%, so operating margin narrowed 1.81 percentage points to 36.67%. This was the second consecutive quarterly decline from 38.81% in Q2FY26 to 38.48% in Q3FY26 and 36.67% in Q4FY26. The YoY comparison remains better, with margin up 0.99 percentage points as costs grew more slowly than revenue.
Interest, not other income, shaped earnings quality
Interest expense rose 561.76% QoQ, while profit before tax fell 21.80% despite operating profit being broadly flat. Other income contributed only 1.86% of pre-tax profit, so it was not a material support to reported earnings. The lower tax rate, down 2.68 percentage points YoY and 2.67 percentage points QoQ, partly cushioned the pressure on net profit.
Stock reaction was mild versus its results history
The stock rose +1.93% on the first trading day after the results, then was down 3.75% after five sessions and up 8.47% after 30 sessions. The initial move was below the company's median absolute post-results move of 3.38%; historically, seven of eight observed results reactions were positive. The five-session performance was weaker than the typical direction in that history.
Healthcare margin remains above the reported peer median
Torrent's 36.67% standalone operating margin was 13.29 percentage points above the 23.38% median for 48 Healthcare peers that had reported the same quarter. It ranked 45th from the bottom, placing it above most of the reported peer set on this measure.
Q4FY26 at a glance
Standalone figures as filed with NSE — cross-checked against an independent source.
| Line item | Q4FY26 | Q3FY26 | QoQ | YoY |
|---|---|---|---|---|
| Revenue | ₹2,735 cr | ₹2,599 cr | +5.23% | +12.41% |
| Other income | ₹11 cr | ₹-18 cr | — | — |
| Expenses | ₹1,732 cr | ₹1,599 cr | +8.32% | +10.67% |
| Operating profit | ₹1,003 cr | ₹1,000 cr | +0.30% | +15.55% |
| Operating margin (%) | 36.67% | 38.48% | — | — |
| Interest | ₹225 cr | ₹34 cr | +561.76% | +378.72% |
| Depreciation | ₹197 cr | ₹191 cr | +3.14% | +3.68% |
| Profit before tax | ₹592 cr | ₹757 cr | -21.80% | -4.82% |
| Tax | ₹125 cr | ₹180 cr | -30.56% | -15.54% |
| Net profit | ₹467 cr | ₹577 cr | -19.06% | -1.48% |
| EPS (₹) | ₹13.80 | ₹17.04 | -19.01% | -1.43% |
Operating margin of 36.67% compares with a Healthcare sector median of 23.38% across 48 peers that have reported Q4FY26.
How the stock reacted
| Window | Stock | vs NIFTY |
|---|---|---|
| Results day | +1.93% | +0.61% |
| Next session | -0.76% | — |
| 5 sessions | -3.75% | -2.76% |
| 15 sessions | -0.43% | — |
| 30 sessions | +8.47% | — |
Volume on the results session was 3.58× its 20-day average.
What to watch
- Whether operating margin stabilises after falling to 36.67% from 38.48% in Q3FY26.
- Whether interest expense moves down from Rs 225 cr after Rs 34 cr in Q3FY26.
- Whether revenue growth remains above +12.41% YoY while expenses grow more slowly than revenue.